• LAST PRICE
    5.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 5.0000
  • Day Range
    ---
  • 52 Week Range
    Low 5.0000
    High 5.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesJMKJ
Coretag Inc
1.1B
-27,777.8x
---
United StatesNNOX
Nano-X Imaging Ltd
570.4M
-5.1x
---
United StatesCBUS
Cibus Inc
525.4M
-1.0x
---
United StatesSLP
Simulations Plus Inc
825.6M
78.8x
+3.18%
United StatesPLSE
Pulse Biosciences Inc
462.7M
-9.8x
---
United StatesLAB
Standard BioTools Inc
1.0B
-2.9x
---
As of 2024-03-29

Company Information

Coretag, Inc. is focused on the development of cancer imaging and targeted radiotherapy, based on its Necrosis Targeting Platform Technology (NTPT). The Company developed NTPT as a result of the discovery of a group of cyanine dyes which have selective targeting properties for intracellular proteins. These proteins become available for binding only when the cell membrane loses its integrity, which occurs once a cell has become necrotic. The Company has developed a portfolio of products that address high unmet needs in oncology. The Company develops targeted radiotherapy with 177Lu (lutetium) and 121Pb (lead) for the treatment of rapidly growing tumors and metastasis. It also develops targeted diagnostics with 89Zr (zirconium) and 111In (indium) for detecting and quantifying necrotic tissue in the human body.

Contact Information

Headquarters
7325 Oswego RoadLIVERPOOL, NY, United States 13090
Phone
315-451-7515
Fax
---

Executives

Chief Executive Officer, Chief Financial Officer, Company Secretary, Director
Joseph Passalaqua

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1B
Revenue (TTM)
$0.00
Shares Outstanding
225.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
-27,777.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.